HE4 (WFDC2) is a new biomarker (it was first associated with the human epididymis). HE4 belongs to the family of whey acidic four-disulfide core (WFDC) proteins. Fujirebio Diagnostics, Inc. has developed an ELISA kit for the quantitative measurement of HE4 in patient blood. The HE4 test has been cleared by the US Food and Drug Administration for use as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. The test can currently be ordered through Quest Diagnostics and LabCorp within the United States. Visit the U.S. website to learn more about HE4.
The HE4 assay is to be used as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. Testing should be used in conjunction with other clinical methods used for monitoring ovarian cancer. For additional information please contact us at firstname.lastname@example.org.